College of Agriculture
Allylix is combining leading edge research in molecular genetics, biochemistry and structural biology from the University of Kentucky and The Salk Institute for Biological Studies to produce natural products called terpenes for the flavor & fragrance and insect repellent markets. Using its extensive intellectual property, Allylix can create diverse collections of fine chemicals, especially chiral chemicals, rapidly generating molecules that possess the properties of natural products, as well as scale up production of high-value single entity compounds.
Equine Diagnostic Solutions
Founded by David Granstrom, Maxwell H. Gluck Equine Research Center, as Equine Biodiagnostics, Equine Diagnostic Solutions (EDS) is an equine specialty testing laboratory that focuses primarily on molecular and serologic testing for medically and economically significant equine infectious diseases including EPM and strangles. EDS is located at the Coldstream Research Campus.
Based on patented technology developed by the University of Kentucky Entomology Department, MosquitoMate provides improved means to control important mosquitoes, including mosquitoes that transmit human disease. The ecologically-based approach takes advantage of mosquito biology: while male mosquitoes don’t bite, they are the best at finding female mosquitoes. Current chemical pesticides are broadcast in the hope of killing mosquitoes, but this approach fails to reach many hidden breeding areas. MosquitoMate’s ‘self-delivering,’ non-GMO method is based upon a naturally occurring bacterium that stops mosquito eggs from hatching, and it can be used alone or combined with existing chemical methods. In addition to improved mosquito control, the outcome is a reduced need for chemical pesticides.
Naprogenix is commercializing its bioprospecting technology targeting the pharmaceutical, nutraceutical, and agrochemical industries. Their proprietary research is aimed at discovering novel plant-based natural products through Natural Products Genomics ™ (NPG). NPG is a functional genomics platform technology that combines a novel mutagenic strategy with a uniquely efficient cell culture screening process. Its objective is to identify and express the gene sequences that are responsible for the production of naturally occurring, secondary, small molecule metabolites, or botanical compounds, with desired biological activity. Based on the research of John Littleton, molecular and biomedical pharmacology.
New Ace Research Company
P.O. Box 273, Versailles, KY, 40383-0273 | 859.873.4739
Develops new technologies and treatments for use in various human and animal diseases. Based on the research of David Granstrom and Tom Tobin, Maxwell H. Gluck Equine Research Center.
Paratechs applies advances in insect molecular biology to develop insect control and natural product technologies. Paratech's technologies address market-proven needs with significant advantages over existing technologies. Two proprietary technologies are under development. The first provides an alternative to conventional methods of agricultural pest control by utilizing proteins from insect pathogens to inhibit the growth and development of insect pests. The second uses genes derived from insect viruses to enhance protein expression and reduces input costs in biomanufacturing. Paratech's technologies are based on the research of UK entomologist Bruce Webb.
George Wagner | 859.257.5974
PhylloTech is pioneering the use of protein-based biofungicides to fight pathogens in the agricultural industry by developing new techniques for the sustainable production of industrial biomaterials in plants. The technology is from George Wagner, UK plant & soil sciences and PhylloTech CSO, and Ryan Shepherd, CTO and UK Ph.D. in plant biochemistry & molecular biology.
Fred Payne | 859.257.3000 ext. 220
WTT, founded in 1988, was based on the research of founders David Watt (College of Medicine, cellular and molecular biochemistry), Dan Tai (College of Pharmacy), and Tom Tobin (College of Agriculture, Gluck Equine Research Center). WTT developed enzyme-linked immunosorbent assay (ELISA ) tests for drugs of abuse in race horses and dogs. They had developed 29 diagnostic tests before the company was sold to the international food and animal safety company, Neogen in 1991. Neogen’s Animal Safety Division is based in Lexington, Ky.